Medicare
AHA statement on 2022 OPPS and PFS final rules from Executive Vice President Stacey Hughes.
AHA commented on recent Medicare Payment Advisory Commission discussions on possible approaches to reducing spending on Part B drugs and biologicals, improving alternative payment models, and revising the hospital wage index.
AHA comments on recent Medicare Payment Advisory Commission discussions on possible approaches to reducing spending on Part B drugs and biologicals, improving alternative payment models, and revising the hospital wage index.
The Next Generation Accountable Care Organization model reduced gross Medicare spending in performance years 2016 to 2019 by $667 million (1.2%), according to findings released by the Centers for Medicare & Medicaid Services.
Sens. Susan Collins, R-Maine, and Tina Smith, D-Minn., and Reps. Paul Tonko, D-N.Y., and Bill Huizenga, R-Mich., have introduced the Medicare Mental Health Inpatient Equity Act (S. 3061/H.R. 5674), AHA-supported legislation that would eliminate the Medicare program’s 190-day lifetime limit on…
A coalition of hospital and physician organizations, including the AHA, urge the Centers for Medicare & Medicaid Services to give Medicare accountable care organizations the option to use pre-pandemic spending benchmarks to set financial targets beginning in performance year 2022.
The Centers for Medicare & Medicaid Services should withdraw a proposed Medicare demonstration that would implement new program integrity audits for all inpatient rehabilitation facilities in four states, AHA told the agency again.
The AHA urges congressional leaders to include in year-end legislation provisions to extend the moratorium on Medicare sequester cuts and to prevent the Statutory Pay-As-You-Go Act of 2010 (Statutory PAYGO) sequester from taking effect at the end of this session of Congress.
At least 93% of clinicians eligible to participate in Medicare’s Merit-based Incentive Payment System earned a small positive adjustment in 2017 through 2019, according to a report released by the Government Accountability Office.
The Centers for Medicare & Medicaid Services released premium and cost-sharing information for Medicare Advantage and Part D prescription drug plans for the 2022 calendar year.